- Report
- May 2025
- 199 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- June 2025
- 296 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- March 2025
- 150 Pages
Global
From €2918EUR$3,250USD£2,485GBP
€4355EUR$4,850USD£3,708GBP
- Report
- June 2024
- 183 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- February 2024
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- October 2023
- 145 Pages
Global
From €2828EUR$3,150USD£2,408GBP
Head and neck cancer diagnostics is a field of medical diagnostics that focuses on the detection and diagnosis of cancers of the head and neck. This includes cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Diagnostic tests used to detect head and neck cancer include imaging tests such as X-rays, CT scans, MRI scans, and PET scans, as well as biopsies and endoscopies. These tests are used to identify the location and extent of the cancer, as well as to determine the best course of treatment.
Head and neck cancer diagnostics is an important part of the overall diagnostics market, as early detection and diagnosis of these cancers can lead to better outcomes for patients. Companies in this market include Siemens Healthineers, Philips Healthcare, GE Healthcare, Hologic, and FUJIFILM SonoSite. Show Less Read more